What is 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
3% w/v Sodium Chloride Intravenous Infusion BP is a sterile, hypertonic solution intended for intravenous administration. It contains 3 grams of sodium chloride per 100 mL, equating to 513 mEq/L of both sodium and chloride ions. This high-concentration solution is used in specialized clinical settings to correct significant electrolyte disturbances.
- Purpose: Corrects severe symptomatic hyponatremia (low blood sodium levels) and reduces elevated intracranial pressure.
- Category: Electrolyte replacement / Osmotic agent.
- Form: Ready-to-use 500 mL plastic bag for IV infusion.
- Use environment: Administered only under close medical supervision in hospitals or intensive care units.
Because of its hypertonic nature, this solution must be used cautiously to avoid complications from rapid sodium correction or fluid overload. It's not suitable for routine fluid replacement.
How to use 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
3% Sodium Chloride should only be administered by healthcare professionals trained in electrolyte management and fluid therapy. Its use requires continuous clinical and laboratory monitoring.
- Route: Intravenous infusion, preferably via a central venous line due to hyperosmolarity.
- Preparation: The solution is pre-mixed and ready to use; do not mix with other IV medications unless compatibility is confirmed.
- Administration:
- Begin with a slow infusion rate, typically 1–2 mL/kg/hour depending on sodium deficit.
- In emergencies (e.g., acute cerebral edema), rapid bolus doses of 100–150 mL over 30–60 minutes may be warranted.
- Monitoring:
- Check serum sodium every 2–4 hours during infusion.
- Monitor fluid input/output, neurological status, and blood pressure.
- Precautions: Do not use if the solution is discolored or contains particulates. Always check bag integrity before use.
The key to safe administration is gradual correction of sodium to avoid central pontine myelinolysis (CPM) or osmotic demyelination syndrome.
Mode of Action 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This hypertonic saline solution exerts its effects through osmotic and electrolyte-restoring mechanisms. It helps move water from intracellular to extracellular compartments and replenishes sodium levels.
- Osmotic Shift: High sodium concentration increases extracellular fluid osmolality, drawing water out of swollen cells (especially brain cells), relieving cerebral edema.
- Sodium Repletion: Supplies sodium ions to correct hypoosmolar states such as severe hyponatremia.
- Electrolyte Balancing: Stabilizes action potentials and nerve conduction by restoring sodium levels.
- Short-Term Plasma Volume Expansion: Temporary increase in intravascular volume due to osmotic fluid shift.
The solution does not provide calories or other electrolytes (like potassium or bicarbonate) and is meant for acute, controlled correction of sodium deficits rather than maintenance therapy.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP Interactions 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This medication may interact with other agents affecting fluid balance, kidney function, or electrolyte regulation. Caution and professional evaluation are essential when co-administering with:
- Diuretics (e.g., furosemide): May lead to further electrolyte imbalance, especially hypokalemia or hypomagnesemia.
- Corticosteroids: Promote sodium and fluid retention, possibly increasing the risk of hypertension or edema.
- ACE Inhibitors / ARBs: Can impair renal sodium handling and increase the risk of hypernatremia or renal complications.
- Desmopressin (DDAVP): May alter the renal response to sodium infusion and exacerbate hyponatremia if not discontinued timely.
- Anticonvulsants (e.g., carbamazepine): May affect serum sodium via SIADH, necessitating cautious monitoring.
Always consult with pharmacy and nephrology or critical care teams when integrating 3% NaCl infusion into a patient’s therapeutic regimen.
Dosage of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
The dosage must be individualized and calculated based on the patient’s serum sodium level, weight, and clinical status. Overcorrection should always be avoided.
- Typical Dosing Strategy:
- Slow infusion: 1–2 mL/kg/hour.
- Acute bolus: 100–150 mL over 30–60 minutes (e.g., for seizure or severe cerebral edema).
- Calculation: Sodium deficit (mEq) = (Target Na⁺ – Actual Na⁺) × TBW × 0.6 (TBW = total body water, based on weight and sex)
- Correction Target:
- Do not increase serum sodium by more than 8–10 mEq/L in 24 hours.
- In high-risk patients, limit to 6 mEq/L per 24 hours.
All dosing should be guided by specialist teams with the ability to monitor labs and adjust treatment in real-time.
Possible side effects of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
While beneficial in specific situations, 3% sodium chloride carries a risk of side effects, particularly when administered rapidly or without monitoring.
- Common Adverse Effects:
- Dry mouth, thirst
- Injection site discomfort or irritation
- Fluid retention or edema
- Serious Side Effects:
- Hypernatremia
- Pulmonary edema (especially in cardiac or renal patients)
- Hypertension
- Seizures (if sodium levels rise too rapidly)
- Osmotic demyelination syndrome (ODS)
Patients should be observed continuously during therapy, and any signs of adverse effects should prompt reevaluation of dosing strategy and rate of correction.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP Contraindications 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
This medicine should not be administered in certain clinical conditions due to the risk of severe complications.
- Absolute Contraindications:
- Hypernatremia
- Severe fluid retention or edema
- Congestive heart failure
- Relative Contraindications:
- Renal failure (especially anuric states)
- Uncontrolled hypertension
- Liver cirrhosis with ascites
Use with caution in patients at risk for fluid overload or electrolyte shifts. A multidisciplinary approach is advised before initiating therapy.
Storage of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP
Proper storage ensures safety and efficacy of the product.
- Storage Temperature: Store at 20–25°C (68–77°F); excursions between 15–30°C may be acceptable short-term.
- Packaging: Supplied in sealed plastic IV bags; keep in original packaging until ready for use.
- Do Not Freeze: Freezing may cause container rupture or salt precipitation.
- Inspection: Always check for particulates, discoloration, or bag leakage before administration.
- Shelf Life: Use before the expiration date printed on the packaging. Do not use if the solution appears cloudy or contains sediment.
Keep out of reach of children and store in a secure, temperature-controlled environment within hospital or pharmacy settings.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP features an exceptional active ingredient renowned for its potent effects, comprising Sodium chloride. This powerful formulation provides a superior solution for addressing diverse health concerns. With 30mg/ml concentration and an easily manageable Infusion/Solution for, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP .
Welcome to Dwaey, specifically on 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP page.
This medicine contains an important and useful components, as it consists of Sodium chloride.
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP is available in the market in concentration 30mg/ml and in the form of Infusion/Solution for.
QATAR PHARMA is the producer of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP and it is imported from QATAR,
The most popular alternatives of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP are listed downward .
-
Active Substance
-
Size
-
Indications
-
Type
-
Company
Frequently Asked Questions
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP should be stored according to the instructions provided by QATAR PHARMA.
In general, it is recommended to store 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP. Some medications, including
3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 30mg/ml,
and the specific recommendations of QATAR PHARMA.
The effects of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 30mg/ml, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP with or without food may vary depending on the medication
and the recommendations of QATAR PHARMA. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in children or elderly individuals may depend on various factors, including
the specific medication, type Infusion/Solution for, and the recommendations of QATAR PHARMA. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of 3% w/v SODIUM CHLORIDE INTRAVENOUS INFUSION BP in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments